多瑞医药(301075.SZ)：拟出售不超过1.31%已回购股份
DUO RUI PHARMADUO RUI PHARMA(SZ:301075) Ge Long Hui·2025-12-19 12:30

Core Viewpoint - Duori Pharmaceutical (301075.SZ) announced the plan to sell repurchased shares through a centralized bidding method, with a total of up to 1,044,500 shares, representing 1.31% of the company's total share capital [1] Group 1 - The sale period for the repurchased shares will be from January 14, 2026, to July 13, 2026, excluding the periods prohibited by the China Securities Regulatory Commission and the Shenzhen Stock Exchange [1] - The selling price of the repurchased shares will be determined based on the secondary market price [1]